Corticobasal degeneration: Evaluation of cortical atrophy by means of hemispheric surface display generated with MR images

Radiology

Volumn 216, Issue 1, 2000, Pages 31-38

  Kitagaki, Hajime ^a,b   Hirono, Nobutsugu ^a   Ishii, Kazunari ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Brain PET; Brain, atrophy; Brain, MR; Brain, SPECT; Brain, volume; Dementia; Magnetic resonance (MR), image processing; Magnetic resonance (MR), three dimensional; Magnetic resonance (MR), volume measurement

Indexed keywords

ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0033934892     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.216.1.r00ma0531     Document Type: Article

References (33)

1. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18:20-33.
2. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989; 112: 1171-1192.
3. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology 1990; 40:1203-1212.
4. Lang AE, Riley DE, Bergeron C, Cortical-basal ganglionic degeneration. In: Calne DB, ed. Neurodegenerative disease. Philadelphia, Pa: Saunders, 1994; 877-894.
5. Grisoli M, Fetoni V, Savoiardo M, Girotti F, Bruzzone MG. MRI in corticobasal degeneration. Eur J Neurol 1995; 2:547-552.
6. Ballan G, Tison F, Dousset V, Vidailhet M, Agid Y, Henry P. Study of cortical atrophy with magnetic resonance imaging in corticobasal degeneration. Rev Neurol 1998; 154: 224-227. [French]
7. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging 1996; 6:222-226.
8. Kitagaki H, Mon E, Yamaji S, et al. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology 1998; 208:431-439.
9. Yasuda M, Mori E, Kitagaki H, et al. Apolipoprotein E e4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am J Psychiatry 1998; 155:779-784.
10. Hashimoto M, Kitagaki H, Imamura T, et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998; 51:357-362.
11. Mori E, Ikeda M, Hirono N, Kitagaki H, Imamura T, Shimomura T. Amygdalar volume and emotional memory in Alzheimer's disease. Am J Psychiatry 1999; 156: 216-222.
12. Mori E, Mitani Y, Yamadori A. Usefulness of Japanese version of the Mini-Mental State test in neurological patients. Jpn J Neuropsychol 1985; 1:82-90.
13. Mohs RC, Rosen WG, Davis KL. The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983; 19:448-450.
14. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48:119-125.
15. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64:184-189.
16. Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997; 120:1541-1552.
17. Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998; 65:717-721.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
19. Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by positron emission tomography. J Nucl Med 1996; 37:1159-1165.
20. Kobashi S, Kamiura K, Hata Y, Yamato K. In: Chen Y, Hirota K, Yen J, eds. Soft computing: proceedings of 1996 Asian Fuzzy Systems Symposium. Piscataway, NJ: Institute of Electrical and Electronics Engineers, 1996; 164-175.
21. Dunn OJ. Multiple comparisons using rank sums. Technometrics 1964; 6:241-252.
22. Schneider JA, Wats RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neurologic and clinical heterogeneity. Neurology 1997; 48:959-969.
23. Tsuchiya K, Ikeda K, Uchihara T, Oda T, Shimada H. Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan. Acta Neuropathol 1997; 94:416-424.
24. Wakabayashi K, Oyanagi K, Makifuchi T, et al. Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol (Berl) 1994; 87:545-553.
25. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141:1356-1364.
26. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416-418.
27. Kertetsz A. Frontotemporal dementia, Pick disease, and corticobasal degeneration: one entity or 3? (letter). Arch Neurol 1997; 54:1427-1428.
28. Denny-Brown D, Myers JS, Horenstein S. The significance of perceptual rivalry resulting from parietal lobe lesions. Brain 1952, 75:433-471.
29. Nagahama Y, Fukuyama H, Turjanski N, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Mov Disord 1997; 12:691-696.
30. Nagasavva H, Tanji H, Nomura H, et al. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci 1996; 139:210-217.
31. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord 1995; 10: 179-187.
32. Blin J, Vidailhet MJ, Pillon B, Dubois B, Feve JR, Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 1992; 7:348-354.
33. Eidelberg D, Dhawan V, Moeller JR, et al. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991; 54:856-862.